Zogenix $ZGNX has two products, ZX008, low-dose fenfluramine for various types of epilepsies; and Relday, a long-acting SC risperidone injection  for schizophrenia. ZX008 initiated phase 3 in January 2016 for Dravet’s syndrome, a rare type of epilepsy syndrome occurring very early in life.

As people have discussed in our chatroom, ZGNX investors need to look at fenflur safety/efficacy data from last year closely.

*** L3 or above subscription required to read the rest of the article ... Login or Subscribe/Upgrade here